Tsingke Information

Tsingke Biotech is a leader in synthetic biology, committed to building a world-class gene factory. By integrating AI-driven molecular manufacturing with expertise in gene reading, editing, and writing, the company has developed a fully independent R&D ecosystem covering the complete biotechnology workflow from raw materials to sequencing. Within this ecosystem, Tsingke Biotech develops three intelligent manufacturing platforms focused on high-throughput oligonucleotide screening, antibody discovery and production, and microbial strain engineering and screening. Powered by in-house reagents, proprietary synthesizers, and automated systems, these platforms deliver scalable and precise solutions for gene design, synthesis, and functional molecule discovery, enabling applications across biopharmaceuticals, industrial biotechnology, agriculture, food, and environmental science. Headquartered in Beijing, Tsingke Biotech operates 70,000 m² of facilities, holds more than 300 patents, and maintains certified quality, environmental, and occupational health management systems. Its production environment is ISO 13485-certified, and the company holds Class II and Class III medical device licenses. Driven by the values of Quality, Innovation, Dedication, and mutually beneficial collaboration, Tsingke Biotech is advancing biotechnology through integrated solutions that support industry-wide progress.